 oral intraves bacillu calmette-guerin immunoprophylaxi bladder carcinoma total patient superfici transit cell carcinoma underw transurethr resect bladder tumor patient stage pta transit cell carcinoma carcinoma situ concurr malign patient treatment group control group transurethr resect studi oral bacillu calmette-guerin bcg group transurethr resect bladder tumor bcg moreau intraves bcg group transurethr resect bladder tumor bcg patient control group tumor recurr mean followup month patient oral bcg group recurr mean followup month patient intraves group recurr mean followup incid complic intraves oral bcg group result intraves bcg effect immunotherapi oral bcg patient intraves bcg administr